Vivak Parkash - <institution>York Biomedical Research Institute, Hull York Medical School, University of York</institution>, York, <country>UK</country>

基本信息

浏览量：0

职业迁徙

个人简介

Dual role: Clinical Research Fellow at the University of York, working on a controlled human infection model for cutaneous leishmaniasis; Infectious Diseases & General internal medicine doctor at Sheffield Teaching Hospitals NHS Foundation Trust.

研究兴趣

论文共 21 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety, effectiveness, and skin immune response in a controlled human infection model of sand fly transmitted cutaneous leishmaniasis

Vivak Parkash,Helen Ashwin,Shoumit Dey,Jovana Sadlova,Barbora Vojtkova,Katrien Van Bocxlaer,Rebecca Wiggins, David Thompson,Nidhi Sharma Dey,Charles L. Jaffe,Eli Schwartz,Petr Volf,Charles J. N. Lacey,Alison M. Layton,Paul M. Kaye

crossref（2024）

引用0浏览0引用

Development of a Core Outcome Measure Instrument; "leishcom_lcl", for Localised Cutaneous Leishmaniasis

Shalindra Ranasinghe,Sujai Senarathne,Vijani Somaratne,Charles J. N. Lacey,Surangi Jayakody, Amila Wickramasinghe,Indira Kahawita,Hiro Goto,Mitali Chatterjee,Jose A. L. Lindoso,Vivak Parkash, Surya J. Chaudhuri,Renu Wickremasinghe,Nilay K. Das,Paul M. Kaye,Alison M. Layton

PLoS neglected tropical diseasesno. 8 (2024): e0012393-e0012393

引用0浏览0WOS引用

Safety and Reactogenicity of a Controlled Human Infection Model of Sand Fly-Transmitted Cutaneous Leishmaniasis

NATURE MEDICINE (2024)

引用0浏览0WOSNATURE引用

GD03 Identifying Core Outcome Domains and Development of a Cutaneous Leishmaniasis Core Outcome Measure for Use in Clinical Practice and Trials

Sujai Senarathne,Shalindra Ranasinghe,Indira Kahawita,Vijani Somaratne, Amila Wickramasinghe,Vivak Parkash,Charles Lacey,Paul Kaye,Alison Layton

BRITISH JOURNAL OF DERMATOLOGY (2023)

引用0浏览0引用

Outpatient Parenteral Antimicrobial Therapy for Leishmaniasis: 13 Years’ Experience at a Large UK Infectious Diseases Centre

Vivak Parkash,Nicholas Laundy,Oyewole Christopher Durojaiye

Transactions of the Royal Society of Tropical Medicine and Hygiene（2023）

引用0浏览0WOS引用

The Utility of a Controlled Human Infection Model for Developing Leishmaniasis Vaccines

Paul M. Kaye,Vivak Parkash,Alison M. Layton,Charles J. N. Lacey

Vaccines for Neglected Pathogens: Strategies, Achievements and Challengespp.263-279, (2023)

引用0浏览0引用

37 Pathway to a Controlled Human Infection Model for Leishmania Major

Vivak Parkash,Helen Ashwin,Georgina Jones,Jovana Sadlova,Barbora Vojtkova,Charles Jaffe,Petr Volf,Alison Layton,Paul Kaye,Charles Lacey

Clinical Infection in Practice (2022): 100198

引用0浏览0引用

Patterns of Thromboembolic Pulmonary Vascular Disease in COVID-19

Yousef Shahin,Smitha Rajaram,Vivak Parkash,James M. Wild,David G. Kiely,Andrew J. Swift

Pulmonary circulation（2021）

引用6浏览0WOS引用

Overcoming Roadblocks in the Development of Vaccines for Leishmaniasis

Paul M. Kaye,Sakshi Mohan,Carsten Mantel,Melissa Malhame,Paul Revill,Epke Le Rutte,Vivak Parkash,Alison M. Layton,Charles J. N. Lacey,Stefano Malvolti

Expert review of vaccines（2021）

引用10浏览0WOS引用

Vaccines Against Leishmaniasis: Using Controlled Human Infection Models to Accelerate Development

Vivak Parkash,Paul M. Kaye,Alison M. Layton,Charles J. Lacey

EXPERT REVIEW OF VACCINES（2021）

引用8浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn